Search for other papers by Alessandro Brancatella in
Google Scholar
PubMed
Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
Introduction Thyroid hormones are one of the most prescribed drugs in Western countries, mostly for the management of hypothyroidism either spontaneous or after thyroidectomy for benign diseases and differentiated thyroid cancer (DTC). The aim
Search for other papers by David T Broome in
Google Scholar
PubMed
Search for other papers by Gauri B Gadre in
Google Scholar
PubMed
Search for other papers by Ehsan Fayazzadeh in
Google Scholar
PubMed
Search for other papers by James F Bena in
Google Scholar
PubMed
Search for other papers by Christian Nasr in
Google Scholar
PubMed
Introduction Thyroid cancer is currently the third fastest rising cancer diagnosis in the United States. The National Cancer Institute indicates that there were 52,070 new cases of thyroid cancer diagnosed in 2019 and an estimated 52,890 newly
Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital/ University Medical Center Utrecht, Utrecht, The Netherlands
Search for other papers by S C Clement in
Google Scholar
PubMed
Search for other papers by W E Visser in
Google Scholar
PubMed
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Search for other papers by C A Lebbink in
Google Scholar
PubMed
Search for other papers by D Albano in
Google Scholar
PubMed
Search for other papers by H L Claahsen-van der Grinten in
Google Scholar
PubMed
Search for other papers by A Czarniecka in
Google Scholar
PubMed
Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Search for other papers by R P Dias in
Google Scholar
PubMed
Search for other papers by M P Dierselhuis in
Google Scholar
PubMed
Search for other papers by I Dzivite-Krisane in
Google Scholar
PubMed
Search for other papers by R Elisei in
Google Scholar
PubMed
Search for other papers by A Garcia-Burillo in
Google Scholar
PubMed
Search for other papers by L Izatt in
Google Scholar
PubMed
Search for other papers by C Kanaka-Gantenbein in
Google Scholar
PubMed
Search for other papers by H Krude in
Google Scholar
PubMed
Search for other papers by L Lamartina in
Google Scholar
PubMed
Search for other papers by K Lorenz in
Google Scholar
PubMed
Search for other papers by M Luster in
Google Scholar
PubMed
Search for other papers by R Navardauskaitė in
Google Scholar
PubMed
Search for other papers by M Negre Busó in
Google Scholar
PubMed
Search for other papers by K Newbold in
Google Scholar
PubMed
Search for other papers by R P Peeters in
Google Scholar
PubMed
Search for other papers by G Pellegriti in
Google Scholar
PubMed
Search for other papers by A Piccardo in
Google Scholar
PubMed
Search for other papers by A L Priego in
Google Scholar
PubMed
Search for other papers by A Redlich in
Google Scholar
PubMed
Search for other papers by L de Sanctis in
Google Scholar
PubMed
Search for other papers by M Sobrinho-Simões in
Google Scholar
PubMed
Search for other papers by A S P van Trotsenburg in
Google Scholar
PubMed
Search for other papers by F A Verburg in
Google Scholar
PubMed
Search for other papers by M Vriens in
Google Scholar
PubMed
Search for other papers by T P Links in
Google Scholar
PubMed
Developmental Endocrinology Research Group, Royal Hospital for Children, University of Glasgow, Glasgow, UK
Office for Rare Conditions, University of Glasgow, Glasgow, UK
Search for other papers by S F Ahmed in
Google Scholar
PubMed
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Search for other papers by H M van Santen in
Google Scholar
PubMed
End Results Program, the annual percent change in pediatric thyroid cancer incidence increased from 1.1% per year (1973–2006) to 9.6% per year (2006–2013) ( 1 ). The increasing incidence is likely the result of better detection of small and early
Search for other papers by Danuta Gąsior-Perczak in
Google Scholar
PubMed
Search for other papers by Iwona Pałyga in
Google Scholar
PubMed
Search for other papers by Monika Szymonek in
Google Scholar
PubMed
Search for other papers by Artur Kowalik in
Google Scholar
PubMed
Search for other papers by Agnieszka Walczyk in
Google Scholar
PubMed
Search for other papers by Janusz Kopczyński in
Google Scholar
PubMed
Search for other papers by Katarzyna Lizis-Kolus in
Google Scholar
PubMed
Search for other papers by Anna Słuszniak in
Google Scholar
PubMed
Search for other papers by Janusz Słuszniak in
Google Scholar
PubMed
Search for other papers by Tomasz Łopatyński in
Google Scholar
PubMed
Search for other papers by Ryszard Mężyk in
Google Scholar
PubMed
The Faculty of Health Sciences, Jan Kochanowski University, Kielce, Poland
Search for other papers by Stanisław Góźdź in
Google Scholar
PubMed
The Faculty of Health Sciences, Jan Kochanowski University, Kielce, Poland
Search for other papers by Aldona Kowalska in
Google Scholar
PubMed
Introduction Increased access to imaging techniques and fine-needle aspiration cytology (FNAC) has resulted in an increase in the rate of detection of differentiated thyroid cancer (DTC) in recent years ( 1 , 2 , 3 , 4 ). The increase in
Search for other papers by Carina Hasenoehrl in
Google Scholar
PubMed
Search for other papers by Gert Schwach in
Google Scholar
PubMed
SFL Chicken CAM Lab, Institute of Pathophysiology and Immunology, Medical University of Graz, Graz, Austria
Search for other papers by Nassim Ghaffari-Tabrizi-Wizsy in
Google Scholar
PubMed
Search for other papers by Robert Fuchs in
Google Scholar
PubMed
Search for other papers by Nadine Kretschmer in
Google Scholar
PubMed
Search for other papers by Rudolf Bauer in
Google Scholar
PubMed
Search for other papers by Roswitha Pfragner in
Google Scholar
PubMed
Introduction Medullary thyroid carcinomas (MTC) arise from the parafollicular C-cells of the thyroid and account for 5–10% of all thyroid cancers ( 1 , 2 ). MTCs are calcitonin-producing tumors that occur sporadically in 70–80% of the cases
Search for other papers by Sandeep Kumar Parvathareddy in
Google Scholar
PubMed
Search for other papers by Abdul K Siraj in
Google Scholar
PubMed
Search for other papers by Zeeshan Qadri in
Google Scholar
PubMed
Search for other papers by Saeeda O Ahmed in
Google Scholar
PubMed
Search for other papers by Felisa DeVera in
Google Scholar
PubMed
Search for other papers by Saif Al-Sobhi in
Google Scholar
PubMed
Search for other papers by Fouad Al-Dayel in
Google Scholar
PubMed
Search for other papers by Khawla S Al-Kuraya in
Google Scholar
PubMed
Introduction Papillary thyroid carcinoma (PTC) is the commonest subtype of thyroid cancer, accounting for 80–90% of all thyroid cancers, and is generally associated with favorable outcome ( 1 , 2 ). The incidence of PTC has increased
Search for other papers by Rasmus Reinke in
Google Scholar
PubMed
Search for other papers by Stefano Christian Londero in
Google Scholar
PubMed
Search for other papers by Martin Almquist in
Google Scholar
PubMed
Search for other papers by Lars Rejnmark in
Google Scholar
PubMed
Search for other papers by Lars Rolighed in
Google Scholar
PubMed
thyroid surgeons or parathyroid + thyroid surgeons in (A) cancer patients, (B) Graves’ patients and (C) goitre patients over time. (D) Distribution of surgeon over time and hypoparathyroidism from 2012 to 2021. Over time, the risk of hypoPT
Search for other papers by Huy Gia Vuong in
Google Scholar
PubMed
Search for other papers by Uyen N P Duong in
Google Scholar
PubMed
Search for other papers by Ahmed M A Altibi in
Google Scholar
PubMed
Search for other papers by Hanh T T Ngo in
Google Scholar
PubMed
Search for other papers by Thong Quang Pham in
Google Scholar
PubMed
Search for other papers by Hung Minh Tran in
Google Scholar
PubMed
Search for other papers by Greta Gandolfi in
Google Scholar
PubMed
Search for other papers by Lewis Hassell in
Google Scholar
PubMed
Introduction PTC is the most common histologic type of thyroid cancer, and its incidence has been increasing over the years ( 1 ). PTCs rarely behave as aggressive tumors clinically, with a cancer-specific mortality rate less than 5% ( 2
Search for other papers by Wei Sun in
Google Scholar
PubMed
Search for other papers by Boyuan Zheng in
Google Scholar
PubMed
Search for other papers by Zhihong Wang in
Google Scholar
PubMed
Search for other papers by Wenwu Dong in
Google Scholar
PubMed
Search for other papers by Yuan Qin in
Google Scholar
PubMed
Search for other papers by Hao Zhang in
Google Scholar
PubMed
Introduction The most prevalent endocrine malignancy is thyroid cancer, which accounts for 1% of all malignancies. Recently, morbidity caused by thyroid cancer has increased by three-fold ( 1 , 2 ). Histologically, the most common type of
Search for other papers by Chan Sub Park in
Google Scholar
PubMed
Search for other papers by Jihye Choi in
Google Scholar
PubMed
Search for other papers by Min-Ki Seong in
Google Scholar
PubMed
Search for other papers by Sung-Eun Hong in
Google Scholar
PubMed
Search for other papers by Jae-Sung Kim in
Google Scholar
PubMed
Search for other papers by In-Chul Park in
Google Scholar
PubMed
Search for other papers by Hyesil Seol in
Google Scholar
PubMed
Search for other papers by Woo Chul Noh in
Google Scholar
PubMed
Search for other papers by Hyun-Ah Kim in
Google Scholar
PubMed
Introduction Estradiol is a key factor for tumorigenesis and prognosis of hormone receptor (HR)-positive breast cancer. Although estradiol is produced mainly by the ovary in premenopausal women, the adrenal gland and adipocytes are also